Our Journey
Krishgen Biosystems, a proprietor based firm, was established as a new identity to support our growth. Krishgen Biosystems Pvt Ltd was established and set up on 7th July 2024.
Launched the world's first range of ELISA for bispecific antibody drugs. Krishgen also inaugurated a new ISO 13485 certified manufacturing facility in Bhiwandi, India, spanning 10,000 square feet.
Therapeutic Drug Monitoring ELISA range expanded to include 300+ new ELISA, the world’s largest range. Krishgen also broke ground for our new state-of-the-art production facility.
Krishgen supports COVID-19 research by manufacturing a wide range of SARS-CoV-2 ELISA and well as develops one of the India’s first COVID-19 PCR tests for diagnostic use. The ELISA range included assays for detection of specific antigen or antibody, as well as neutralizing antibodies to all the variants.
Krishgen becomes the first in the world to commercialize assays for Insulin Analogs and GLP1 Agonists for diabetes and metabolism research. To date, Krishgen remains the leader in ELISA for these two product categories.
Through a growing demand in the US and Japanese markets, Krishgen began partnering with global distributors for ELISA. Krishgen also opens the doors to a larger manufacturing lab.
A range of mAb-based Pharmacokinetic and Anti-Drug Antibody (ADA) ELISA launched for popular mAb drug targets. At the time, Krishgen ADA were one of the only quantitative kits available worldwide (with others being qualitative).
To further support the Indian biotech and pharma industry, Krishgen launches its first range of KRIBIOLISATM kits. A step above GENLISATM in quality and validation to match the quality requirements from industry customers, KRIBIOLISATM Bioprocess Contamination kits were an instant success.
Customs Bonded Warehouse established to enable us to offer users in India customs duty benefits.
Krishgen increases its ELISA portfolio and launches the GENLISATM Gold Ring Cytokine ELISA range. GENLISATM Gold Ring represents Krishgen’s validation and commitment to quality.
Following the advice of industry partners, Krishgen begins R&D for manufacturing its own ELISA kits. First products developed are immunoassays for popular cytokines in Human, Rat and Mouse samples.
Research and life sciences reagents and tools are added onto the product catalog through distribution arrangements with leading US and Europe companies.
Krishgen is established by Kalpesh and Neelam Jain as a distributor for international diagnostics companies in Mumbai, India.